Thomas C. Aquilina, MD

Vice President, Drug Safety and Pharmacovigilance
Acadia Pharmaceuticals Inc.

Poster(s):

• (SLA-164) Mortality in Patients With Parkinson’s Disease Psychosis Using Pimavanserin Versus Other Antipsychotics
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET